semaglutide barcelona Ozempic Treatment in Barcelona: Medical Weight Loss at Santé Barcelona Spain August 21 2025

While tirzepatide currently shows greater average weight-loss results in clinical studies, semaglutide remains one of the most researched and successful obesity treatments available

How to Talk to Your Doctor About GLP-1 Weight Loss Drugs Chronic Diseases That GLP-1s Are FDA-Approved to Treat GLP-1s for Heart Disease In March 2024, the FDA approved the GLP-1 drug Wegovy (semaglutide) to treat heart disease in people who are overweight or who have obesity the first approval for a GLP-1 medication outside of diabetes or weight loss

Popoviciu M, Pduraru L, Yahya G, Metwally K, Cavalu S

Long-acting glucagon-like peptide-1 receptor agonist-status December 2018